Medtecs International exploring Covid-19 test-kit tie-up for Philippine market
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
CATALIST-LISTED medical equipment supplier Medtecs International Corp will distribute a Taiwanese biologics firm's Covid-19 rapid tests in the Philippines, under a letter of intent signed and disclosed by the board on Thursday.
Under the planned pact, Medtecs will promote the test kit from Enimmune Corp, a vaccine development and marketing joint venture by Taiwan-listed vaccine manufacturer Adimmune Corp and other investors.
The terms of the partnership are subject to definitive agreements that will be inked between Medtecs and Enimmune Corp, the Medtecs board said. It added that the company will make more announcements when there are material developments on the strategic tie-up.
Medtecs noted in its bourse filing that the company and Enimmune Corp "seek to leverage each other's strengths" in exploring test-kit distribution opportunities in the Philippines, once the relevant approvals are obtained.
The agreement is not expected to have any material impact on Medtecs' consolidated earnings or net tangible assets per share for the year to Dec 31, 2021, it added.
Fuelled by the Covid-19 pandemic, Medtecs' share price surged by more than 2,600 per cent in 2020, rising from 3.7 Singapore cents to S$1.
Navigate Asia in
a new global order
Get the insights delivered to your inbox.
The counter last closed on Thursday at S$1.10, down by S$0.02 or 1.79 per cent, before the announcement.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
